Repositioning Candidate Details
| Candidate ID: | R1607 |
| Source ID: | DB16697 |
| Source Type: | investigational |
| Compound Type: | biotech |
| Compound Name: | Glutazumab |
| Synonyms: | -- |
| Molecular Formula: | -- |
| SMILES: | -- |
| DrugBank Description: | Glutazumab is a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein exerting anti-diabetic effects. |
| CAS Number: | -- |
| Molecular Weight: | |
| DrugBank Indication: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | Glucagon-like peptide 1 receptor agonist |
| Inclusion Criteria: | Target associated |
